CABGpreHAB - a Feasibility Study Protocol

June 25, 2025 updated by: Dorte Bæk Olsen, Rigshospitalet, Denmark

CABGpreHAB- Home-based Multimodal Prehabilitation (CABGpreHAB) for Elective Patients Awaiting CABG-surgery - a Feasibility Study Protocol

Patients with ischemic heart disease (IHD) awaiting coronary artery bypass graft (CABG) surgery often face challenges like advanced age, frailty, comorbidities, and physical inactivity. These factors, combined with the physiological and psychological stress of surgery, can hinder postoperative recovery. Traditionally, strategies to improve surgical outcomes focus on the intra- and postoperative periods. However, the pre-surgery waiting period offers a "window of opportunity" for prehabilitation, which aims to enhance patients' functional capacity through exercise, nutrition, and psychological support.

The CABGpreHAB feasibility study evaluates the feasibility of a home-based multimodal prehabilitation intervention for patients awaiting elective CABG surgery. This randomized pilot study compares the intervention plus usual care to usual care alone, assessing feasibility outcomes like recruitment, retention, attrition, fidelity, and adherence. The study aims to optimize a subsequent full-scale randomized controlled trial (RCT) and improve patient outcomes by leveraging the pre-surgery period for prehabilitation.

Study Overview

Detailed Description

Advanced age, frailty, comorbidity, and physical inactivity are often present in patients with ischemic heart disease (IHD) awaiting coronary artery bypass graft surgery (CABG). These characteristics, as well as the physiological impact of having surgery, are significant homeostatic disturbances where patients postoperatively suffer from physical symptoms and a lack of return to independence. Cardiac surgery invariably induces varying degrees of physiological stress, impacting multiple organ systems, and imposes a psychological burden. As age increases, patient complexity and comorbid burden grow more common in patients undergoing cardiac surgery; innovative strategies are required to alleviate the risk of adverse outcomes. Strategies to improve outcomes from surgery and accelerate return to baseline levels have traditionally focused on the intra- and postoperative period, nevertheless, the waiting period before surgery might offer an opportunity for improving the safety and outcome of the surgical intervention and improving patients' motivation in postoperative rehabilitation and recovery time. Prehabilitation is a newly introduced term that reflects a proactive process of enhancing an individual's functional capacity between diagnosis and scheduled surgery, intending to improve the patient's capacity to withstand the upcoming physiologic stress of surgery and thus avoid complications. This period of awaiting surgery is proposed as a "window of opportunity" to address poor nutritional status, low physical fitness, and high emotional distress. The role of multimodal prehabilitation combining exercise training, nutritional optimization, and psychological support, in patients with IHD awaiting CABG surgery, is sparse and unknown in a Danish setting

Objective:

This CABG preHAB feasibility study is conducted to evaluate the feasibility of delivering a homebased multimodal prehabilitation intervention for patients awaiting elective CABG surgery with the purpose to optimize a subsequent full-scale RCT.

Design:

The CABGpreHAB feasibility study is designed as a randomized pilot study, aiming to assess the feasibility of a multimodal prehabilitation intervention plus usual care versus usual care alone in patients awaiting elective CABG surgery. It is an investigator-initiated study designed as an open-label, single-center randomized controlled feasibility study (allocation ratio 1:1) with blinded outcome assessment, designed to assess the method proposed for use in a larger RCT.

Study population:

Patients aged more than 18 years awaiting elective CABG-surgery

Primary outcomes:

Feasibility outcomes include:

Recruitment and retention rates. The recruitment rate will be determined by the number of individuals participating in the study out of those who are eligible/admissible but refuse to participate. First, the investigators will evaluate the number of patients that can be included in the study during the inclusion period. A proportion of 60% or more of patients awaiting elective CABG surgery who are eligible for the study is acceptable. Retention will be assessed by the percentage of participants who remain in the study from the beginning to the end of the study (30 days post-surgery).

Attrition rates. Attrition is defined by the number of individuals who consent to participate in the study but drop out before the end of the intervention period, regardless of group allocation.

Fidelity. Fidelity of delivery of the webcam-based exercise training intervention will be assessed qualitatively by 8-10 semi-structured interviews, the day before surgery, by a research nurse.

Adherence to the interventions will be measured by using the number of telephone counselling and tele-exercise sessions delivered out of the theoretical number that could have been delivered based on the surgical wait time of each participant. Adherence to the home-based tele-exercise training sessions and telephone counselling by assessing the number of sessions applied in the intervention group. This will be collected by the patient's recorded physical activity logbook, by weekly phone calls, and by accelerometer data. Adherence with the prehabilitation program will be assessed against the target of individuals achieving > 70% of the prescribed exercise program (self-reported) + during the study follow-up with phone calls. Inclusion in the CABGpreHAB study must be attractive to at least 30% of eligible patients who meet the inclusion criteria. The interventions must be widely accepted, with at least 70% of included participants completing 70% or more of the planned sessions in the intervention group. Safety of the intervention will be determined based on the number and nature of adverse events (AE).

Secondary outcomes:

Secondary outcomes will assess the patients' responses to the multimodal prehabilitation programme, and data will be collected on explorative outcomes, measured at baseline, the day before surgery and 30 days PO.

Study Type

Interventional

Enrollment (Estimated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Copenhagen, Denmark, 2100
        • Recruiting
        • The Department of Heart and Lung Surgery, Copenhagen University hospital Rigshospitalet
        • Contact:
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Planned to have elective isolated first-time CABG surgery.
  • 18 years or older
  • Two weeks or more before surgery
  • Speaks and understands Danish.
  • Gives written informed consent.

Exclusion Criteria:

  • Patient with unstable angina pectoris and/ or MI during the last two weeks.
  • Left main stem stenosis >50%
  • Left ventricular ejection fraction < 35%
  • Significant ventricular arrhythmia
  • Orthopedic or neurologic preconditions precluding exercise training.
  • Inability to attend the prehabilitation program due to physical limitations.
  • Patients who have cognitive deficits that would disqualify prehabilitation.
  • Severe heart failure, NYHA Class IV
  • Lack of capacity to consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: CABGpreHAB multimodal prehabilitation intervention + usual care

Patients randomized to the multimodal prehabilitation programme will, besides usual care, receive home-based preoperative interventions that consist of:

Web-based exercise intervention supervised by skilled physiotherapists and delivered via a tablet. Each session lasts 60 minutes, three times per week for the prehabilitation period. Patients will be instructed to perform daily exercise tasks such as brisk walking and sit-to-stand exercises.

Phone call and consultation delivered by a specialised nurse once a week. This consultation will deliver psychosocial support, equipping patients with coping strategies to mitigate stress, anxiety, and depression. Furthermore, nutritional advice will take place at these consultations, as well as advice on smoking cessation and alcohol cessation.

Multimodal prehabilitation interventions (CABGpreHAB):

  • Home-based exercise intervention delivered by a skilled physiotherapist via a web-based application.
  • Nutritional intervention
  • Psycho-educative intervention
  • Smoking cessation
  • Alcohol cessation
Other: Control group
Participants assigned to the control group will receive usual care.
This includes standard information about CABG surgery, pre- and postoperative care, and postoperative physical activity advice. Patients are either admitted days before or on the day before surgery. They receive written materials and links to animated videos about preparing for surgery. This preparation includes counseling with a multidisciplinary team, including a department nurse, a physiotherapist, a cardiac anesthesiologist, and a surgeon.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feasibility outcome: recruitement rate
Time Frame: Through study completition, an average of 1 year
Determined by the number of individuals participating in the study out of those eligible during the inclusion period.
Through study completition, an average of 1 year
Feasibility outcome: Attrition rates
Time Frame: Up to 30 days post surgery index
Defined by the numbers of individuals who give consent to participate, but drop out before study ends.
Up to 30 days post surgery index
Feasibility outcome: Fidelity
Time Frame: preoperative
Fidelity of delivery on the web-based exercise training intervention will be assessed qualitatively by semi-structured interviews
preoperative
Feasibility outcome: Adherence rates
Time Frame: Preoperative
Adherence will be assessed by measuring the number of telephone counseling and exercise sessions delivered during the intervention period.
Preoperative
Feasibility outcome: Safety
Time Frame: From enrolement to the day before surgery
Safety of the intervention will be determined based on the number and nature of adverse events.
From enrolement to the day before surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Exercise capacity
Time Frame: Three times: at baseline, preoperative and 30 days post surgery index
6MWT measures total walking distance in meters completed in six minutes
Three times: at baseline, preoperative and 30 days post surgery index
Muscle strength
Time Frame: Three times: at baseline, preoperative and 30 days post surgery index
30 seconds sit-to-stand measured by numbers of sit-to-stands in 30 seconds
Three times: at baseline, preoperative and 30 days post surgery index
Muscle strength handgrip
Time Frame: At baseline and preoperative
Measured in kilograms using a hand-held dynamometer
At baseline and preoperative
Bodycomposition
Time Frame: At baseline and preoperative

Using a Bioelectrical Impedance Analyzer (BIA), body composition estimation:

fat mass in kilograms,

Fat mass as a percentage of weight,

Fat-free mass in kilograms,

Fat-free mass as a percentage of weight

At baseline and preoperative
Nutritional status
Time Frame: At baseline and preoperative

Weight and height combined to report BMI in kg/m^2,

and

Screened by the NRS2002 score

At baseline and preoperative
Daily physical activity
Time Frame: Three times: at baseline, preoperative and 30 days post surgery index

SENS motion accelerometer measures minutes of physical activity as

steps, Cyckling running Standing Laying

Three times: at baseline, preoperative and 30 days post surgery index
HRQOL
Time Frame: Three times: at baseline, preoperative and 30 days post surgery index
The Questionnaire SF-12 measures overall health status
Three times: at baseline, preoperative and 30 days post surgery index
Heart-specific QoL
Time Frame: Three times: at baseline, preoperative and 30 days post surgery index
The Questionnaire HeartQoL measures health-related quality of life in patients with ischemic heart disease
Three times: at baseline, preoperative and 30 days post surgery index
Anxiety
Time Frame: Three times: at baseline, preoperative and 30 days post surgery index
The State-Trait Anxiety Inventory Questionnaire measures two disitnc types of anxiety
Three times: at baseline, preoperative and 30 days post surgery index
Depression
Time Frame: Three times: at baseline, preoperative and 30 days post surgery index
The PHQ-4 Questionnaire measures depression and anxiety
Three times: at baseline, preoperative and 30 days post surgery index
Sense of coherence
Time Frame: At baseline
The SOC-13 Questionnaire assesses an individual´s ability to manage stress and maintain health
At baseline
Self-efficacy/self-management
Time Frame: Three times: at baseline, preoperative and 30 days post surgery index
The PAM13 Questionnaire assesses an individual's knowledge, skill, and confidence for self-management
Three times: at baseline, preoperative and 30 days post surgery index
Tobacco uses status
Time Frame: Three times: at baseline, preoperative and 30 days post surgery index
Self-Reported Questionnaire
Three times: at baseline, preoperative and 30 days post surgery index
Alcohol uses status
Time Frame: Three times: at baseline, preoperative and 30 days post surgery index
Self-Reported Questionnaire
Three times: at baseline, preoperative and 30 days post surgery index

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Complications postoperatively
Time Frame: From date of surgery and up to 30 days postopetively.
Rates of pneumonia, atelectasis, hemorrhage, cardiac arrhythmias, and delirium will be measured postoperatively
From date of surgery and up to 30 days postopetively.
ICU-LOS
Time Frame: From date and time of surgery until the date and time of discharge to the ward.
ICU-LOS will be calculated in hours
From date and time of surgery until the date and time of discharge to the ward.
LOS
Time Frame: From date of surgery until date of discharge from the ward
LOS will be calculated in days
From date of surgery until date of discharge from the ward
DAOH30
Time Frame: From date of surgery and up to 30 days postopetively.
DAOH30 will be calculated in days
From date of surgery and up to 30 days postopetively.
Participating in Cardiac rehabilitation
Time Frame: At 30 days postoperatively
Participation will be calculated in percentage
At 30 days postoperatively
Bloodtest
Time Frame: At baseline and postoperatively day 4
HGB measured in mmol/l Albumin measured in g/l CRP measured in mg/l Creatinine measured in micromol/l
At baseline and postoperatively day 4

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ida E Hoejskov, PhD, Department of Heart Disease, Rigshospitalet, Copenhagen University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 24, 2025

Primary Completion (Estimated)

June 18, 2026

Study Completion (Estimated)

July 18, 2026

Study Registration Dates

First Submitted

May 19, 2025

First Submitted That Met QC Criteria

June 16, 2025

First Posted (Actual)

June 24, 2025

Study Record Updates

Last Update Posted (Actual)

June 29, 2025

Last Update Submitted That Met QC Criteria

June 25, 2025

Last Verified

June 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe